(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TAKEDA PATIENT SUPPORT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

TAKEDA PATIENT SUPPORT

ST13

US500000097227793

Class

44

Filing

97227793

Registration

7930874

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

58

Latest update

09/03/2025

Trademark type

Combined

Nice classes

44

Filing date

01/19/2022

Registration date

09/02/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/02/2025

Last transaction

09/03/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/23/2021

First use in commerce

11/23/2021

Drawing code

3

Owner type

16

Owner location

Osaka, JP

Examiner

AVENT, TEAGUE

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a stylized red convex weighted line situated above a smaller stylized red convex line both positioned to frame the word "Takeda" in red, with the words "patient" and "support" underneath in purple, and a circular image of three human figures with arms extended in red, purple and teal.

Holders and representatives

Holders

Takeda Pharmaceutical Company Limited

Representatives

KARL M. ZIELAZNICKI TROUTMAN PEPPER LOCKE LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Pharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve understanding by patients and caregivers about pharmaceuticals

Publications

History of USPTO decisions and trademark events.

58 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/02/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

09/02/2025

EXPT

EXPARTE APPEAL TERMINATED

08/14/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/14/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/14/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/11/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/11/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/22/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/06/2025

GNRT

NON-FINAL ACTION E-MAILED

05/06/2025

CNRT

SU - NON-FINAL ACTION - WRITTEN

05/06/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/13/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/13/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/13/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/13/2025

EXPI

EX PARTE APPEAL-INSTITUTED

03/13/2025

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

03/13/2025

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

03/13/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/11/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/11/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/11/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

12/19/2024

GNFR

FINAL REFUSAL E-MAILED

12/19/2024

CNFR

SU - FINAL REFUSAL - WRITTEN

12/19/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/30/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/30/2024

ALIE

ASSIGNED TO LIE

09/30/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/04/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/11/2024

GNRT

NON-FINAL ACTION E-MAILED

04/11/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

04/11/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/03/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/03/2024

IUAF

USE AMENDMENT FILED

02/09/2024

EISU

TEAS STATEMENT OF USE RECEIVED

02/09/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/03/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/08/2023

PUBO

PUBLISHED FOR OPPOSITION

08/08/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/19/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/06/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/12/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/12/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

06/12/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/11/2023

GNFR

FINAL REFUSAL E-MAILED

04/11/2023

CNFR

FINAL REFUSAL WRITTEN

04/11/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/10/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/10/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/11/2022

GNRT

NON-FINAL ACTION E-MAILED

08/11/2022

CNRT

NON-FINAL ACTION WRITTEN

08/11/2022

DOCK

ASSIGNED TO EXAMINER

08/04/2022

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

01/26/2022

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

01/26/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/26/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/25/2022

NWAP

NEW APPLICATION ENTERED

01/22/2022

Continuous trademark protection

Get notified about every new filing that threatens TAKEDA PATIENT SUPPORT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.